Latest Treatment of Acute Kidney Injury in Cirrhosis
Author:
- 15 May 2020
- journal article
- research article
- Published by Springer Nature in Current Treatment Options in Gastroenterology
- Vol. 18 (2) , 281-294
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Recent advances in our understanding of hepatorenal syndromeNature Reviews Gastroenterology & Hepatology, 2012
- Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosisGut, 2011
- Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2010
- EASL clinical practice guidelines for HFE hemochromatosisJournal of Hepatology, 2010
- Terlipressin and Albumin vs Albumin in Patients With Cirrhosis and Hepatorenal Syndrome: A Randomized StudyGastroenterology, 2008
- A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal SyndromeGastroenterology, 2008
- Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot studyJournal of Hepatology, 2007
- Implication of inflammation‐related cytokines in the natural history of liver cirrhosisLiver International, 2004
- Suppression of Proinflammatory Cytokines Interleukin-1β and Tumor Necrosis Factor-α in Astrocytes by a V1Vasopressin Receptor Agonist: A cAMP Response Element-Binding Protein-Dependent MechanismJournal of Neuroscience, 2004
- Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosisHepatology, 2002